Sarana Meditama Metropolitan (SAME) - Total Assets

Latest as of March 2026: Rp5.77 Trillion IDR ≈ $338.01 Million USD

Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) holds total assets worth Rp5.77 Trillion IDR (≈ $338.01 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Sarana Meditama Metropolitan (SAME) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Sarana Meditama Metropolitan - Total Assets Trend (2009–2025)

This chart illustrates how Sarana Meditama Metropolitan's total assets have evolved over time, based on quarterly financial data. Check Sarana Meditama Metropolitan earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Sarana Meditama Metropolitan - Asset Composition Analysis

Current Asset Composition (December 2025)

Sarana Meditama Metropolitan's total assets of Rp5.77 Trillion consist of 8.7% current assets and 91.3% non-current assets.

Asset Category Amount (IDR) % of Total Assets
Cash & Equivalents Rp0.00 2.6%
Accounts Receivable Rp283.91 Billion 4.9%
Inventory Rp54.35 Billion 0.9%
Property, Plant & Equipment Rp4.24 Trillion 73.1%
Intangible Assets Rp92.35 Billion 1.6%
Goodwill Rp449.25 Billion 7.7%

Asset Composition Trend (2009–2025)

This chart illustrates how Sarana Meditama Metropolitan's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Sarana Meditama Metropolitan.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Sarana Meditama Metropolitan's current assets represent 8.7% of total assets in 2025, an increase from 0.0% in 2009.
  • Cash Position: Cash and equivalents constituted 2.6% of total assets in 2025, the same as 2.6% in 2009.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2009.
  • Asset Diversification: The largest asset category is property, plant & equipment at 73.1% of total assets.

Sarana Meditama Metropolitan Competitors by Total Assets

Key competitors of Sarana Meditama Metropolitan based on total assets are shown below.

Company Country Total Assets
Lifestance Health Group Inc
NASDAQ:LFST
USA $2.15 Billion
Extendicare Inc
TO:EXE
Canada CA$1.07 Billion
Compass Pathways Plc
NASDAQ:CMPS
USA $210.35 Million
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
Indonesia Rp9.64 Trillion
Bait Bakfar Ltd
TA:BKFR
Israel ILA2.25 Billion
VITA 34 AG
XETRA:V3V
Germany €168.26 Million
P3 Health Partners Inc
NASDAQ:PIII
USA $674.16 Million
Premier Health of America Inc
V:PHA
Canada CA$42.63 Million

Sarana Meditama Metropolitan - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.54 0.72 2.23
Quick Ratio 0.49 0.63 2.12
Cash Ratio 0.00 0.00 0.26
Working Capital Rp-460.09 Billion Rp-187.63 Billion Rp189.07 Billion

Sarana Meditama Metropolitan - Advanced Valuation Insights

This section examines the relationship between Sarana Meditama Metropolitan's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.29
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 4.4%
Total Assets Rp5.80 Trillion
Market Capitalization $299.72 Million USD

Valuation Analysis

Below Book Valuation: The market values Sarana Meditama Metropolitan's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Sarana Meditama Metropolitan's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Sarana Meditama Metropolitan (2009–2025)

The table below shows the annual total assets of Sarana Meditama Metropolitan from 2009 to 2025.

Year Total Assets Change
2025-12-31 Rp5.80 Trillion
≈ $339.98 Million
+4.39%
2024-12-31 Rp5.56 Trillion
≈ $325.69 Million
+3.61%
2023-12-31 Rp5.36 Trillion
≈ $314.35 Million
+4.37%
2022-12-31 Rp5.14 Trillion
≈ $301.18 Million
+3.87%
2021-12-31 Rp4.95 Trillion
≈ $289.97 Million
+161.89%
2020-12-31 Rp1.89 Trillion
≈ $110.72 Million
-15.37%
2019-12-31 Rp2.23 Trillion
≈ $130.84 Million
-11.71%
2018-12-31 Rp2.53 Trillion
≈ $148.19 Million
+47.49%
2017-12-31 Rp1.71 Trillion
≈ $100.48 Million
+18.10%
2016-12-31 Rp1.45 Trillion
≈ $85.08 Million
+20.67%
2015-12-31 Rp1.20 Trillion
≈ $70.50 Million
+157.84%
2014-12-31 Rp466.66 Billion
≈ $27.34 Million
+23.57%
2013-12-31 Rp377.65 Billion
≈ $22.13 Million
+29.88%
2012-12-31 Rp290.78 Billion
≈ $17.04 Million
-3.99%
2011-12-31 Rp302.86 Billion
≈ $17.75 Million
-5.47%
2010-12-31 Rp320.38 Billion
≈ $18.77 Million
-1.33%
2009-12-31 Rp324.71 Billion
≈ $19.03 Million
--

About Sarana Meditama Metropolitan

JK:SAME Indonesia Medical Care Facilities
Market Cap
$299.72 Million
Rp5.12 Trillion IDR
Market Cap Rank
#14919 Global
#174 in Indonesia
Share Price
Rp298.00
Change (1 day)
-0.67%
52-Week Range
Rp246.00 - Rp428.00
All Time High
Rp755.00
About

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Ma… Read more